According to Fortune Business Insights, the global chlorhexidine gluconate dressing market was valued at USD 1.03 billion in 2025. The market is projected to grow from USD 1.08 billion in 2026 to USD 1.60 billion by 2034, exhibiting a CAGR of 5.0% during the forecast period from 2026 to 2034. Market growth is being supported by increasing hospital emphasis on infection prevention, rising surgical procedures, and growing critical care admissions, which are contributing to demand for CHG dressings used for device securement and infection prevention. 

Market Overview

The global chlorhexidine gluconate dressing market is witnessing steady expansion due to the growing focus on preventing healthcare-associated infections. Hospitals are increasingly adopting antimicrobial dressings for vascular access because infections associated with catheters can result in serious clinical complications and higher healthcare costs.

CHG dressings combine antimicrobial protection with securement capabilities. Transparent IV securement dressings are particularly useful because healthcare professionals can observe the insertion site without removing the dressing. This can reduce unnecessary dressing changes and help support infection prevention.

The market is segmented by product type, application, end user, and geography. Hospitals and ambulatory surgery centers represent an important end-user group because of their infection-control protocols, higher procurement capacity, and large number of patients requiring vascular access. 

For detailed market insights: https://www.fortunebusinessinsights.com/chlorhexidine-gluconate-dressing-market-119123

Market Trends

A key trend in the chlorhexidine gluconate dressing market is the growing preference for transparent IV securement dressings. These products enable clinicians to monitor catheter insertion sites without removing the dressing, helping reduce unnecessary disruption of the dressing and supporting infection-control practices.

Another important trend is the increasing emphasis on antimicrobial protection for patients with long-term vascular access. Patients using central lines, PICC lines, dialysis catheters, and other vascular devices can be vulnerable to bloodstream infections, increasing demand for antimicrobial dressing solutions.

Product innovation is also shaping the industry. In March 2022, Cardinal Health launched a surgical incise drape using chlorhexidine gluconate with Avery Dennison's BeneHold CHG adhesive technology to help reduce the risk of surgical-site contamination. In February 2021, TIDI Products launched vascular access securement dressings featuring PrevaHexCHX antimicrobial protection. 

Market Drivers

Rising Burden of Catheter-Related Infections

The increasing use of vascular access devices is one of the major drivers of the CHG dressing market. Central venous catheters, PICC lines, dialysis catheters, and peripheral IV lines are increasingly used across healthcare settings, creating a greater need for effective infection prevention around insertion sites.

CHG dressings can help reduce microbial growth around catheter insertion areas and lower the risk associated with catheter-related bloodstream infections. This growing clinical requirement is expected to support the adoption of antimicrobial dressings during the forecast period. 

Increasing Surgical Procedures and Critical Care Admissions

The rising number of surgical procedures and critical care admissions is also contributing to market growth. Healthcare facilities are placing greater emphasis on infection prevention protocols, particularly in settings where patients require invasive devices.

The increasing number of healthcare facilities and growing adoption of advanced infection-prevention products are therefore expected to create sustained demand for CHG dressings. 

Market Restraint

Higher Cost Compared with Standard Dressings

The relatively high cost of CHG dressings compared with conventional transparent films, gauze, and basic securement dressings may restrict market growth. Cost-sensitive hospitals and smaller healthcare facilities may prefer lower-cost alternatives, particularly when budgets are limited.

Procurement teams may also hesitate to adopt higher-priced antimicrobial products in healthcare facilities where infection rates are already well controlled. Such cost considerations can be particularly important in emerging markets and smaller clinical facilities. 

Market Segmentation

By Product Type

Based on product type, the market is segmented into:

  • CHG Transparent IV Securement Dressings
  • CHG Foam/Disc Dressings
  • CHG Gel Pads
  • Others

The CHG transparent IV securement dressings segment is expected to hold the major market share during the forecast period. Their ability to allow clinicians to monitor catheter insertion sites without removing the dressing supports their adoption in hospitals and other healthcare settings. 

By Application

Based on application, the market is divided into:

  • Surgical Site Infections (SSIs)
  • Catheter-Related Bloodstream Infections (CRBSI)
  • Central Line-Associated Bloodstream Infections (CLABSI)
  • Others

The catheter-related bloodstream infections segment is expected to hold the major share. The high clinical risk associated with vascular access devices makes antimicrobial protection particularly important for patients with central lines, PICC lines, dialysis catheters, and long-term IV access. 

By End User

The market is categorized into:

  • Hospitals & ASCs
  • Specialty Clinics
  • Dialysis Centers
  • Others

The hospitals & ASCs segment is expected to account for the largest share. Strong infection-control protocols, larger procurement budgets, and the growing number of hospitals worldwide are supporting demand for CHG dressings in this segment. 

Key Players

The major companies covered in the chlorhexidine gluconate dressing market include:

  • Solventum
  • BD
  • Johnson & Johnson MedTech
  • Datt Mediproducts
  • Avery Dennison Corporation
  • Boen Healthcare Co., Ltd.
  • JCMED
  • Luck Medical Consumables Co., LIMITED
  • Medline Industries, LP
  • Weifang Hota New Material Technology Co., LTD

The market is moderately consolidated, with established companies benefiting from hospital relationships, broad infection-prevention portfolios, and clinically recognized products. 

Regional Analysis

North America held the leading position in the global chlorhexidine gluconate dressing market, accounting for 39.2% of the market in 2025. The region benefits from strong hospital infection-prevention protocols, high adoption of advanced IV securement products, and widespread use of central venous catheters, PICC lines, and dialysis catheters. 

Asia Pacific is anticipated to register the fastest CAGR during the forecast period. Growth is being supported by increasing surgical procedures, expanding dialysis and oncology patient populations, and greater awareness of infection prevention across countries such as China, Japan, India, South Korea, and Australia.

Europe, Latin America, and the Middle East & Africa are also included in the market analysis. Healthcare infrastructure development and increasing attention toward infection prevention are expected to create additional opportunities across these regions. 

Competitive Landscape

The competitive landscape is moderately consolidated, with leading companies focusing on product innovation, antimicrobial technology, strategic partnerships, and expansion of infection-prevention portfolios.

Product launches are an important competitive strategy. Cardinal Health's introduction of a CHG surgical incise drape and TIDI Products' launch of vascular access securement dressings with antimicrobial protection demonstrate the industry's focus on developing products that combine securement with infection prevention.

Companies with established relationships with hospitals and healthcare providers are positioned to benefit from growing procurement requirements for advanced antimicrobial dressings. 

Future Outlook

The future outlook for the chlorhexidine gluconate dressing market remains positive as healthcare providers continue to strengthen infection-prevention practices. Rising surgical volumes, increasing use of vascular access devices, and growing critical care and dialysis patient populations are expected to support demand.

Emerging healthcare markets also represent an important growth opportunity. Developing countries across Asia Pacific, Latin America, and parts of the Middle East are improving hospital infrastructure and increasing their focus on infection prevention. As these healthcare systems modernize, adoption of advanced antimicrobial dressings is expected to increase. 

Get a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/chlorhexidine-gluconate-dressing-market-119123

Conclusion

The global chlorhexidine gluconate dressing market is projected to grow from USD 1.03 billion in 2025 to USD 1.60 billion by 2034, registering a 5.0% CAGR from 2026 to 2034. Rising catheter-related infection risks, increasing surgical procedures, stronger hospital infection-control protocols, and expanding healthcare infrastructure are key factors supporting market growth.

Although higher costs compared with conventional dressings remain a restraint, increasing demand for antimicrobial protection and growing healthcare investment in emerging markets are expected to create new opportunities. Transparent IV securement dressings, catheter-related bloodstream infection applications, and hospitals and ASCs are expected to remain important areas of market development.

Frequently Asked Questions (FAQs)

1. What was the chlorhexidine gluconate dressing market size in 2025?

According to Fortune Business Insights, the global chlorhexidine gluconate dressing market was valued at USD 1.03 billion in 2025.

2. What will be the chlorhexidine gluconate dressing market size by 2034?

The global chlorhexidine gluconate dressing market is projected to reach USD 1.60 billion by 2034.

3. What is the CAGR of the chlorhexidine gluconate dressing market?

The market is expected to grow at a CAGR of 5.0% from 2026 to 2034.

4. Which product type is expected to dominate the chlorhexidine gluconate dressing market?

The CHG transparent IV securement dressings segment is expected to hold the major market share during the forecast period.

5. Which region held the largest share of the chlorhexidine gluconate dressing market in 2025?

North America held the largest share, accounting for 39.2% of the global market in 2025.

Uncover Japan’s Market Trends Explore the Latest Chlorhexidine Gluconate Dressing Market Insights